Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Publication | Closed Access

DOI

Citations

References

2023

Year

Fan Yang, Xiaofang Zheng, Sarene Koh, Jianxi Lu, Jintao Cheng, Panlong Li, Cong Du, Yunhao Chen, Li Yang, Wanxin Chen,

Hepatology International

T Cell TherapyTransplantationHepatologyViral HepatitisMedicineImmunologyHepatitis BHepatitisVirologyLiver DiseaseLiver CancerMessenger RnaHepatitis B VirusLiver TransplantationImmunotherapyRadiation OncologyHepatocellular Carcinoma